| dc.creator | Rosenthal, Luciane d'Avila | |
| dc.creator | Petrarca, Cristiane Rios | |
| dc.creator | Mesenburg, Marilia Arndt | |
| dc.creator | Villela, Marcos Marreiro | |
| dc.date.accessioned | 2023-11-10T20:08:18Z | |
| dc.date.available | 2023-11-10T20:08:18Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | ROSENTHAL, Luciane d'Avila. et al. Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, v. 49, n.6, p. 768-771, 2016. Disponível em: https://www.scielo.br/j/rsbmt/a/Y87zwjmpsR54ZKPbQ9SV8LD/?lang=en#. Acesso em: 9 nov. 2023. | pt_BR |
| dc.identifier.uri | http://guaiaca.ufpel.edu.br/xmlui/handle/prefix/10705 | |
| dc.description.abstract | Introduction: The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology
Service in the City of Pelotas, Southern Brazil. Methods: This study included 200 individuals undergoing cancer treatment and
involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody. Results:
The study found a 5% prevalence of patient seropositivity. Signifi cant variables are presented and discussed in the article.
Conclusions: Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in
Brazil and other Latin American countries. | pt_BR |
| dc.language | eng | pt_BR |
| dc.publisher | Scielo | pt_BR |
| dc.rights | OpenAccess | pt_BR |
| dc.subject | Cancer | pt_BR |
| dc.subject | Chagas disease | pt_BR |
| dc.subject | Trypanosoma cruzi | pt_BR |
| dc.title | Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil | pt_BR |
| dc.type | article | pt_BR |
| dc.identifier.doi | https://doi.org/10.1590/0037-8682-0202-2016 | |
| dc.rights.license | CC BY-NC-SA | pt_BR |
